- Home
- RGS vs STRO Comparison
RGS vs STRO Comparison
Compare RGS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- STRO
- Stock Information
- Founded
- RGS 1922
- STRO 2003
- Country
- RGS United States
- STRO United States
- Employees
- RGS N/A
- STRO N/A
- Industry
- RGS Other Consumer Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RGS Consumer Discretionary
- STRO Health Care
- Exchange
- RGS Nasdaq
- STRO Nasdaq
- Market Cap
- RGS 70.8M
- STRO 76.5M
- IPO Year
- RGS 1991
- STRO 2018
- Fundamental
- Price
- RGS $30.08
- STRO $0.84
- Analyst Decision
- RGS
- STRO Hold
- Analyst Count
- RGS 0
- STRO 7
- Target Price
- RGS N/A
- STRO $1.97
- AVG Volume (30 Days)
- RGS 21.9K
- STRO 450.6K
- Earning Date
- RGS 11-05-2025
- STRO 11-12-2025
- Dividend Yield
- RGS N/A
- STRO N/A
- EPS Growth
- RGS 20.23
- STRO N/A
- EPS
- RGS 46.10
- STRO N/A
- Revenue
- RGS $210,134,000.00
- STRO $104,473,000.00
- Revenue This Year
- RGS N/A
- STRO $65.48
- Revenue Next Year
- RGS N/A
- STRO N/A
- P/E Ratio
- RGS $0.69
- STRO N/A
- Revenue Growth
- RGS 3.52
- STRO N/A
- 52 Week Low
- RGS $15.00
- STRO $0.52
- 52 Week High
- RGS $30.66
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- RGS 67.94
- STRO 44.00
- Support Level
- RGS $28.41
- STRO $0.84
- Resistance Level
- RGS $29.90
- STRO $0.95
- Average True Range (ATR)
- RGS 1.15
- STRO 0.06
- MACD
- RGS -0.05
- STRO -0.00
- Stochastic Oscillator
- RGS 80.81
- STRO 12.16
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.